Rosuvastatin Calcium

CHEMBL1744447 Phase 4 Aprobado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
1001.1 g/mol
LogP
Phase
4

The calcium salt formulation of rosuvastatin used to treat high cholesterol and reduce cardiovascular risk in adults and certain children with inherited cholesterol disorders. Once-daily dosing and availability in multiple strengths allows for flexible treatment individualization.

Peso molecular

1001,1000 g/mol

TPSA

304,00 Ų

Áreas terapéuticas

Mecanismo de acción

Competitive inhibitor of HMG-CoA reductase.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mecanismo

Competitive inhibitor of HMG-CoA reductase.

Estructura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CC(C)c1nc(N(C)S(C)(=O)=O)nc(-c2ccc(F)cc2)c1/C=C/[C@@H](O)C[C@@H](O)CC(=O)[O-].CC(C)c1nc(N(C)S(C)(=O)=O)nc(-c2ccc(F)cc2)c1/C=C/[C@@H](O)C[C@@H](O)CC(=O)[O-].[Ca+2]

InChI

InChI=1S/2C22H28FN3O6S.Ca/c2*1-13(2)20-18(10-9-16(27)11-17(28)12-19(29)30)21(14-5-7-15(23)8-6-14)25-22(24-20)26(3)33(4,31)32;/h2*5-10,13,16-17,27-28H,11-12H2,1-4H3,(H,29,30);/q;;+2/p-2/b2*10-9+;/t2*16-,17-;/m11./s1

Molecular Formula

C44H54CaF2N6O12S2

HBD / HBA

4 / 20

Enlaces Rotables

18

Átomos Pesados

67

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Preguntas frecuentes

The calcium salt formulation of rosuvastatin used to treat high cholesterol and reduce cardiovascular risk in adults and certain children with inherited cholesterol disorders. Once-daily dosing and availability in multiple strengths allows for flexible treatment individualization.

Competitive inhibitor of HMG-CoA reductase.

Yes, Rosuvastatin Calcium is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1744447. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 5282455. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Aviso médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.